Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Pulmonary Hypertension, July 2025 Free Subscription Abstracts Retrieve all available abstracts of the following 151 articles: HTML format

Single Articles

1. TANAKA TD, Shiraishi Y, Kang R, Kohno T, et al
   Residual pulmonary hypertension and clinical outcomes in acute decompensated heart failure patients stratified by left ventricular ejection fraction.
   Eur J Heart Fail. 2025 Jul 4. doi: 10.1002/ejhf.3755.
   PubMed    
   Abstract available
   
   

2. VENKATESH G, Kurup H, Raghuram K, Sasikumar D, et al
   Pulmonary Arterial Hypertension After Repair of Classical Tetralogy of Fallot.
   Turk Kardiyol Dern Ars. 2025;53:358-361.
   PubMed    
   Abstract available
   
   

3. ALKADHEM SM, Alattas AT, AlJubab H, AlJubab AS, et al
   Critical Care Dilemma: Complex Congenital Pulmonary Airway Malformation With Pulmonary Hypertension in a Neonate.
   Cureus. 2025;17:e85279.
   PubMed    
   Abstract available
   
   

4. GORICA E, Spezzini J, Papadopoulou I, Telesca M, et al
   Single nuclei RNA-sequencing unveils alveolar macrophages as drivers of endothelial damage in obese HFpEF-related pulmonary hypertension.
   Cardiovasc Diabetol. 2025;24:268.
   PubMed    
   Abstract available
   
   

5. HOU B, Su S, Ji L, Huayu M, et al
   Luteolin alleviates right ventricular hypertrophy in high altitude pulmonary hypertension rats by regulating PI3K/AKT/mTOR signalling pathway.
   Eur J Pharmacol. 2025 Jul 1:177898. doi: 10.1016/j.ejphar.2025.177898.
   PubMed    
   Abstract available
   
   

6. GAO C, Li J, Feng F, Fu J, et al
   EDIL3 regulates pulmonary artery smooth muscle cell proliferation and migration via integrin alphaVbeta3/ERK1/2 axis in pulmonary hypertension.
   Eur J Pharmacol. 2025 Jul 1:177901. doi: 10.1016/j.ejphar.2025.177901.
   PubMed    
   Abstract available
   
   

7. DU D, Qin J, Hu X, Xu D, et al
   Linking obstructive sleep apnea with pulmonary hypertension via pooled prevalence and causal association: A systematic review, meta-analysis and Mendelian randomization.
   Heart Lung. 2025;74:82-89.
   PubMed    
   Abstract available
   
   

8. SARVANANDA S, Earnshaw S, Hughes I, Sivakumaran P, et al
   Effect of positive airway pressure treatment on pulmonary artery pressure in obstructive sleep apnoea and/or obesity hypoventilation syndrome with pulmonary hypertension: a systematic review and meta-analysis.
   Intern Med J. 2025 Jul 2. doi: 10.1111/imj.70137.
   PubMed    
   Abstract available
   
   

9. HE Y, Li Q, Zhang C, Keller BB, et al
   The genetic epidemiology and genotype-phenotype correlations among Chinese children with idiopathic and heritable pulmonary arterial hypertension.
   Respir Res. 2025;26:231.
   PubMed    
   Abstract available
   
   

10. DONG M, Song M, Liu J
    Atrial septostomy in the management of pulmonary arterial hypertension: past, present, and future.
    Eur J Med Res. 2025;30:552.
    PubMed    
    Abstract available
    
    

11. CHEN C, Xie Z, Ao D, Chen Y, et al
    Transcription factor EB improves hypoxic pulmonary hypertension in fetal rats by suppressing NLRP3 inflammasome activation via induction of mitophagy.
    Sci Rep. 2025;15:20356.
    PubMed    
    Abstract available
    
    

12. ALDAY-RAMIREZ SM, Gomez-Rodriguez CA, Damas-de-Los-Santos F, Zebadua-Torres R, et al
    Venous excess ultrasound and right heart catheterization in pre-capillary pulmonary hypertension.
    J Ultrasound. 2025 Jul 2. doi: 10.1007/s40477-025-01050.
    PubMed    
    Abstract available
    
    

13. ALENEZI F, Costelle A, Lee S, Driehuys B, et al
    The emerging role of hyperpolarized (129)Xe MRI in pulmonary hypertension.
    Expert Rev Respir Med. 2025 Jul 2. doi: 10.1080/17476348.2025.2529543.
    PubMed    
    
    
    

14. ALI HJ, Guha A
    Pulmonary hypertension: diagnostic aspects-what is the role of imaging?
    Curr Opin Cardiol. 2025 Jun 27. doi: 10.1097/HCO.0000000000001241.
    PubMed    
    Abstract available
    
    

15. XU Y, Zhou C, Liu X, Guo W, et al
    [Application of Animal Models in Research on Hypoxia-Related Diseases].
    Sichuan Da Xue Xue Bao Yi Xue Ban. 2025;56:331-338.
    PubMed    
    Abstract available
    
    

16. LAMMI M, Kolstad KD, Saketkoo LA, Khatri A, et al
    Response to "Concerns Regarding PTX-3 Specificity and ROC Interpretation in the Study on Endothelial Biomarkers of SSc-Associated Pulmonary Hypertension".
    Arthritis Care Res (Hoboken). 2025 Jul 1. doi: 10.1002/acr.25589.
    PubMed    
    
    
    

17. WANG Y, Jiang W, Bai S, Zhu Y, et al
    Association between prealbumin levels and pulmonary hypertension in peritoneal dialysis patients: a single-center retrospective cohort study.
    BMC Nephrol. 2025;26:329.
    PubMed    
    Abstract available
    
    

18. SUN T, Che H, Zhang J, Lv Y, et al
    Maternal outcomes among pregnant women with shunt-related congenital heart disease-associated pulmonary hypertension: a retrospective study.
    BMC Anesthesiol. 2025;25:299.
    PubMed    
    Abstract available
    
    

19. DU J, Zhang Y, Hao D, Wang H, et al
    Serum proteomics identify biomarkers and pathogenesis of portopulmonary hypertension diagnosed based on echocardiography.
    Sci Rep. 2025;15:21075.
    PubMed    
    Abstract available
    
    

20. AZAD T, Li L, Wang S, Yue S, et al
    Inhaled nitric oxide as an independent intervention to lower the risk of bronchopulmonary dysplasia in preterm infants (< 33 weeks) with pulmonary hypertension within the initial 3 days of life.
    Sci Rep. 2025;15:22517.
    PubMed    
    Abstract available
    
    

21. AVDEEV SN, Gaynitdinova VV, Merzhoeva ZM, Nuralieva GS, et al
    NT-proCNP as a new biomarker of pulmonary hypertension in patients with COPD.
    Sci Rep. 2025;15:21169.
    PubMed    
    Abstract available
    
    

22. LONG GM, Giourdas AD, Fisher AJ, Lahm T, et al
    Effect of Pre-exercise Dietary Nitrate on Skeletal Muscle Blood Flow in a Rat Model of Pulmonary Hypertension.
    Am J Physiol Regul Integr Comp Physiol. 2025.
    PubMed    
    Abstract available
    
    

23. CROQUETTE M, Larrieu Ardilouze E, Beaufort C, Jutant EM, et al
    Femoral venous stasis index predicts elevated right atrial pressure and mortality in pulmonary hypertension.
    ERJ Open Res. 2025;11:01027-2024.
    PubMed    
    Abstract available
    
    

24. CHEN A, Chen Z, Huang B, Lian G, et al
    Hypoxia-induced histone lactylation promotes pulmonary arterial smooth muscle cells proliferation in pulmonary hypertension.
    Mol Cell Biochem. 2025 Jun 30. doi: 10.1007/s11010-025-05342.
    PubMed    
    Abstract available
    
    

25. ADU-AMANKWAAH J, Shi Y, Song H, Ma Y, et al
    Signaling pathways and targeted therapy for pulmonary hypertension.
    Signal Transduct Target Ther. 2025;10:207.
    PubMed    
    Abstract available
    
    

26. VAN SPIJK JN, Junge HK, Eberhardt C, Wolf N, et al
    Evaluation of Subjective Assessment of Right Heart Size and Function Using Standard 2D-Echocardiographic Recordings in Horses With and Without Pulmonary Hypertension.
    J Vet Intern Med. 2025;39:e70145.
    PubMed    
    Abstract available
    
    

27. IBRAHIM R, Habib A, Olson A, Shrourou F, et al
    Location of Terminal Care in Pulmonary Hypertension.
    CJC Open. 2025;7:832-839.
    PubMed    
    Abstract available
    
    

28. ASHWANT KUMAR D, Mahadevan S
    Concerns Regarding PTX-3 Specificity and ROC Interpretation in the Study on Endothelial Biomarkers of SSc-Associated Pulmonary Hypertension.
    Arthritis Care Res (Hoboken). 2025 Jun 30. doi: 10.1002/acr.25586.
    PubMed    
    
    
    

29. NIU LC, Zhang R, Qi Q, Tang BL, et al
    Astragaloside IV Improves Pulmonary Vascular Endothelial Dysfunction in Pulmonary Arterial Hypertension by Inhibiting Ferroptosis through Modulation of the Calpain-1/TGF-beta/TFRC Pathway.
    Am J Chin Med. 2025;53:1181-1206.
    PubMed    
    Abstract available
    
    

30. YIN Q, Peng W, Yang J, Fan C, et al
    Nobiletin alleviates hypoxia-induced pulmonary hypertension by inhibiting calcium-sensing receptor.
    J Nat Med. 2025 Jun 29. doi: 10.1007/s11418-025-01921.
    PubMed    
    Abstract available
    
    

31. DIAS MAIA P, Seedorf G, Gonzalez T, Bye E, et al
    Development of late pulmonary hypertension after antenatal inflammation in experimental bronchopulmonary dysplasia.
    Pediatr Res. 2025 Jun 28. doi: 10.1038/s41390-025-04223.
    PubMed    
    Abstract available
    
    

32. MURUGESAN P, Zhang Y, Zhang Y, Youn JY, et al
    Novel and superior treatment of pulmonary hypertension with netrin-1 derived, modified and improved small peptides.
    Redox Biol. 2025;85:103710.
    PubMed    
    Abstract available
    
    

33. OBEIDAT M, Vignarajah A, Abdel-Razeq R, Nathir A, et al
    Effects of sodium-glucose cotransport-2 inhibitors treatment in patients with pulmonary hypertension.
    Ther Adv Respir Dis. 2025;19:17534666251351443.
    PubMed    
    Abstract available
    
    

34. TURNER R, Connolly D, Brodbelt D, Cortellini S, et al
    The long-term outcome and changes in tricuspid regurgitation pressure gradient in dogs diagnosed with pulmonary hypertension and Angiostrongylus vasorum infestation.
    J Small Anim Pract. 2025 Jun 27. doi: 10.1111/jsap.13893.
    PubMed    
    Abstract available
    
    

35. SUN X, Hu G, Li Y, Li W, et al
    Gut opportunistic pathogens contribute to high-altitude pulmonary edema by elevating lysophosphatidylcholines and inducing inflammation.
    Microbiol Spectr. 2025;13:e0305724.
    PubMed    
    Abstract available
    
    

36. ALAJBEGOVIC L, Lang IM
    Interventional strategies to unload the right ventricle: a systematic review.
    Expert Rev Respir Med. 2025;19:741-757.
    PubMed    
    Abstract available
    
    

37. BZDEGA K, Deutsch GH, Rydzanicz M, Blaz W, et al
    Decreased Level of TMEM100 in Neonates With Lethal Lung Developmental Disorders due to Abnormalities in SHH-FOXF1 and TBX4-FGF10 Signaling Pathways.
    Am J Med Genet A. 2025 Mar 27:e64071. doi: 10.1002/ajmg.a.64071.
    PubMed    
    Abstract available
    
    

38. LICHTBLAU M, Schwarz EI, Ulrich T, Schneider SR, et al
    Effect of an Overnight Stay at 2,500 Meters on Nocturnal Hypoxemia and Sleep-disordered Breathing in Patients with Pulmonary Vascular Disease: A Randomized Clinical Trial.
    Ann Am Thorac Soc. 2025;22:1053-1061.
    PubMed    
    Abstract available
    
    

39. ZHANG Y, Wang X, Sun X, Zhou Z, et al
    Cardiac MRI optimizes risk stratification accuracy in connective tissue disease-associated pulmonary arterial hypertension: a retrospective cohort study.
    Rheumatology (Oxford). 2025;64:4154-4163.
    PubMed    
    Abstract available
    
    

40. RAKO ZA, Cekay M, Yogeswaran A, Yildiz S, et al
    Echocardiographic Measure of Right Ventricular-Pulmonary Arterial Coupling Predicts Survival in Lung Cancer.
    Ann Am Thorac Soc. 2025;22:1071-1078.
    PubMed    
    Abstract available
    
    

41. YANG Y, Liang L, Pei W, Sun Y, et al
    Interaction of ferroptosis and cuproptosis in the perspective of pulmonary hypertension.
    Front Cardiovasc Med. 2025;12:1611449.
    PubMed    
    Abstract available
    
    

42. CAI Z, Lin S, Jin N, Fu Y, et al
    A Patient With Pulmonary Hypertension Carrying FLNA Loss-of-Function Variant.
    Pulm Circ. 2025;15:e70110.
    PubMed    
    Abstract available
    
    

43. GRYNBLAT J, Coulet F, Montani D
    Cobalamin C deficiency: a rare but treatable genetic cause of pulmonary hypertension.
    Orphanet J Rare Dis. 2025;20:357.
    PubMed    
    
    
    

44. HAN T, Huang Q, Zhai Z, Zhang X, et al
    Nocturnal hypoxemia is associated with poor pulmonary hemodynamics in patients with chronic thromboembolic pulmonary disease.
    Respir Res. 2025;26:239.
    PubMed    
    Abstract available
    
    

45. DAN-ZENG ZG, Bai-Ma YJ, Huang J, Suo-Lang WJ, et al
    Integrative proteomics and metabolomics reveal important pathways and potential biomarkers in high-altitude pulmonary hypertension.
    Sci Rep. 2025;15:24999.
    PubMed    
    Abstract available
    
    

46. NYHAN SM, Gadkari M, Brady T, Martinez Yus M, et al
    Preoperative serum LOXL2 levels are elevated in patients with pulmonary hypertension undergoing mitral valve surgery in a prospective observational cohort study.
    J Appl Physiol (1985). 2025 Jul 10. doi: 10.1152/japplphysiol.00287.2025.
    PubMed    
    Abstract available
    
    

47. KOIZUMI S, Musha I, Toda K, Kawana H, et al
    Management strategy for congenital hyperinsulinism with atrial septal defect and diazoxide-induced pulmonary hypertension.
    Clin Pediatr Endocrinol. 2025;34:188-192.
    PubMed    
    Abstract available
    
    

48. FU ZQ, Sun N, An L
    A case of rapidly progressive fatal pulmonary hypertension in a patient with metastatic bladder cancer: reflections on the early recognition of pulmonary tumour thrombotic microangiopathy.
    J Geriatr Cardiol. 2025;22:596-599.
    PubMed    
    
    
    

49. DAS S, Krithika KG
    Anesthetic management of chronic thromboembolic pulmonary hypertension for surgical pulmonary thromboendarterectomy: A narrative review.
    J Anaesthesiol Clin Pharmacol. 2025;41:418-426.
    PubMed    
    Abstract available
    
    

50. YAKU H, Burkhoff D, Borlaug BA, Lala A, et al
    Oral Levosimendan for the Treatment of Pulmonary Hypertension due to Heart Failure with Preserved Ejection Fraction: Rationale and Design of the LEVEL Trial: Rationale and Design of LEVEL.
    J Card Fail. 2025 Jul 7:S1071-9164(25)00293.
    PubMed    
    Abstract available
    
    

51. SYNN AJ, Nassikas NJ
    Breathing Under Pressure? Air Pollution and Mortality in Pulmonary Hypertension.
    Ann Am Thorac Soc. 2025 Jul 9. doi: 10.1513/AnnalsATS.202507.
    PubMed    
    
    
    

52. WANG DW, Katayama A, Ligon MM, Abuelkasem E, et al
    Portopulmonary hypertension: diagnosis and preoperative management.
    Curr Opin Anaesthesiol. 2025;38:445-451.
    PubMed    
    Abstract available
    
    

53. GAZDA AJ, Ryan JJ
    Pulmonary Vascular Oncology: A New Collaborative Field for Cancer-Related Pulmonary Hypertension.
    Circ Cardiovasc Imaging. 2025 Jul 9:e018601. doi: 10.1161/CIRCIMAGING.125.018601
    PubMed    
    
    
    

54. VIRMANI S, Garg S, Malik I, Dash AC, et al
    Intravenous Levosimendan versus Milrinone: Coronary Sinus Lactate and PA Catheter Derived Parameters in Patients with Pulmonary Hypertension Undergoing Elective Mitral Valve Replacement.
    Ann Card Anaesth. 2025;28:298-304.
    PubMed    
    Abstract available
    
    

55. YU L, Chen X, Wang X, Cui R, et al
    Efficacy and safety of high-flow nasal cannula versus noninvasive ventilation for pulmonary arterial hypertension-associated acute respiratory failure: A retrospective cohort study stratified by the severity of right ventricular dysfunction.
    Medicine (Baltimore). 2025;104:e43185.
    PubMed    
    Abstract available
    
    

56. PEREZ DEL VILLAR C, Prieto-Arevalo R, Garcia-Carreno J, Martinez-Legazpi P, et al
    Validation of noninvasive indices of right ventricular diastolic function. Simultaneous echocardiography and pressure-volume catheterization studies.
    Cardiovasc Ultrasound. 2025;23:15.
    PubMed    
    Abstract available
    
    

57. YAO M, Zhong K, Zheng X, Yang Z, et al
    Identification of LDHA as a Potential Therapeutic Target for Pulmonary Hypertension Through Modulation of Endothelial-To-Mesenchymal Transition.
    J Cell Mol Med. 2025;29:e70692.
    PubMed    
    Abstract available
    
    

58. WENG CT, Tsai YS, Hsu CH, Lee CH, et al
    High occurrence of antiphospholipid antibody-associated thromboembolism in systemic lupus erythematosus with significant pulmonary hypertension: A monocentric retrospective study in southern taiwan.
    J Formos Med Assoc. 2025 Jul 7:S0929-6646(25)00330.
    PubMed    
    Abstract available
    
    

59. JUD P, Douschan P, Sassmann T, Silbernagel G, et al
    Endothelial function and vascular events in patients with limited cutaneous systemic sclerosis (EFVELSS): a prospective observational study.
    Rheumatol Int. 2025;45:166.
    PubMed    
    Abstract available
    
    

60. CHEN YX, Deng ZH, She XW, Gao X, et al
    Mesenchymal stem cell-derived exosomes improve vascular remodeling by inhibiting EGFR/ErbB2 heterodimerization in hypoxic pulmonary hypertension.
    Sci Rep. 2025;15:24303.
    PubMed    
    Abstract available
    
    

61. KARVASARSKI E, Park JS, Savaris S, Beale A, et al
    Pre- and post-capillary exercise contributions to pulmonary hypertension in adults > 45 years.
    J Appl Physiol (1985). 2025 Jul 7. doi: 10.1152/japplphysiol.00148.2025.
    PubMed    
    Abstract available
    
    

62. MA C, Gong C, Wang B, Li Y, et al
    Exploring the Causal Link Between Autoimmune Diseases and Pulmonary Arterial Hypertension: A Bidirectional Mendelian Randomization Study.
    Glob Heart. 2025;20:58.
    PubMed    
    Abstract available
    
    

63. KONDURI A, Sonnen AJ, Lim HM, Schumacher KR, et al
    Prostacyclin Therapy as Adjunctive Treatment for Pulmonary Hypertension in Pediatric Heart Transplantation: A Case Report.
    Pediatr Transplant. 2025;29:e70129.
    PubMed    
    Abstract available
    
    

64. MUKHOPADHYAY I, Singh S, Das N, Tevatia A, et al
    Diagnostic quagmires to miraculous resolutions: pulmonary hypertension in pregnancy.
    BMJ Case Rep. 2025;18:e264211.
    PubMed    
    Abstract available
    
    

65. WANG Y, Zhang Y, Iyer SK, Witschey WR, et al
    Long-term prognostic value of native myocardial tissue relaxation parameters (T1, T2, and T1rho) in patients with precapillary pulmonary hypertension.
    Int J Cardiovasc Imaging. 2025 Jul 5. doi: 10.1007/s10554-025-03451.
    PubMed    
    Abstract available
    
    

66. JAFARI L, Wiedenroth CB, Kriechbaum SD, Grun D, et al
    Transcriptional changes of the extracellular matrix in chronic thromboembolic pulmonary hypertension govern right ventricle remodeling and recovery.
    Nat Cardiovasc Res. 2025 Jul 4. doi: 10.1038/s44161-025-00672.
    PubMed    
    Abstract available
    
    

67. BELAUNZARAN MA, Koenigsberg S, Mathavan A, Mathavan A, et al
    Partial anomalous pulmonary venous return: diagnostic challenges and successful correction in a patient with progressive pulmonary hypertension.
    BMJ Case Rep. 2025;18:e264779.
    PubMed    
    Abstract available
    
    

68. R P, B C, D O, Hw F, et al
    Composite score from the pulmonary hypertension-interstitial lung disease detection tool correlates with invasive right heart catheterization hemodynamics.
    Respir Med. 2025;246:108241.
    PubMed    
    Abstract available
    
    

69. BOUCHERAT O, Bonnet S, Provencher S, Potus F, et al
    Anti-remodeling therapies in pulmonary arterial hypertension.
    Trends Pharmacol Sci. 2025;46:674-691.
    PubMed    
    Abstract available
    
    

70. JIANG DJ, Yang YJ, Wang YZ, Zhang X, et al
    Whole exome sequencing unravels genetic architecture and its clinical implications in pediatric pulmonary arterial hypertension.
    Int J Cardiol. 2025;437:133515.
    PubMed    
    Abstract available
    
    

71. XIE H, Zhao X, Zhang N, Liu J, et al
    Machine learning-based hemodynamics quantitative assessment of pulmonary circulation using computed tomographic pulmonary angiography.
    Int J Cardiol. 2025;437:133457.
    PubMed    
    Abstract available
    
    

72. PEREZ MARTINEZ BO, Rubick GV, Toiv A, Perkins S, et al
    Impact of disease location and laterality on hemodynamic response following pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension.
    JHLT Open. 2025;9:100314.
    PubMed    
    Abstract available
    
    

73. JI Y, Li X, Wang R, Wang Z, et al
    Bioinformatics Analysis Identifies a Potential Key Gene in the Pathogenesis of Pulmonary Hypertension-HSPH1.
    Pulm Circ. 2025;15:e70127.
    PubMed    
    Abstract available
    
    

74. SCALIA IG, Farina JM, Pietri MP, Ali NB, et al
    Association of Pulmonary Hypertension With Outcomes in Kidney Transplant Recipients.
    Kidney Int Rep. 2025;10:2394-2404.
    PubMed    
    Abstract available
    
    

75. LI W, Zhang XC, Qian Y, Yu HR, et al
    Prognostic Value of Cardiac MRI-derived Left Ventricular Layer-specific Strain in Pulmonary Arterial Hypertension.
    Radiol Cardiothorac Imaging. 2025;7:e240334.
    PubMed    
    Abstract available
    
    

76. ABMAN SH, Nikkho SM, Berger RMF, Del Cerro MJ, et al
    Enhancing Drug Development for Paediatric Pulmonary Hypertension-An Integrative Perspective.
    Pulm Circ. 2025;15:e70126.
    PubMed    
    Abstract available
    
    

77. RUAN Y, Wei X, Li Q, Jin Z, et al
    Effect of pulmonary hypertension on the prognosis of patients with severe aortic stenosis after transcatheter aortic valve replacement: a systematic review and meta-analysis.
    BMC Cardiovasc Disord. 2025;25:515.
    PubMed    
    Abstract available
    
    

78. MEDINA-MORALES E, Schiano TD
    Hepatopulmonary Syndrome and Portopulmonary Hypertension.
    Clin Liver Dis. 2025;29:503-525.
    PubMed    
    Abstract available
    
    

79. LEIVA O, Liu O, Kanelidis A, Swat S, et al
    Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review.
    JACC CardioOncol. 2025 Jul 3:S2666-0873(25)00237.
    PubMed    
    Abstract available
    
    

80. QIU H, Chen W, Chen J, Jun L, et al
    FABP4 Inhibitor Improves Right Ventricular Fibrosis in Metabolic Syndrome- Related Pulmonary Hypertension due to Left Heart Disease in Mice.
    FASEB J. 2025;39:e70833.
    PubMed    
    Abstract available
    
    

81. CHAN CC, Teixeira BL, Yang JZ, Poch DS, et al
    Sex Differences Among Patients Treated With Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
    Pulm Circ. 2025;15:e70128.
    PubMed    
    Abstract available
    
    

82. 
    Retraction: Prevalence of pulmonary hypertension and its associated factors among chronic obstructive pulmonary diseases patients at public hospitals of Addis Ababa, Ethiopia, 2024: a facility-based cross-sectional study.
    Front Public Health. 2025;13:1652830.
    PubMed    
    Abstract available
    
    

83. NEWMAN J, Ghani H, Munagala S, Otter E, et al
    Pulmonary Hypertension Global Patient Survey: A Call to Action 2025.
    Pulm Circ. 2025;15:e70130.
    PubMed    
    
    
    

84. EICHSTAEDT CA, Maldonado-Velez G, Machado RD, Graf S, et al
    Adaptation of ACMG/AMP Guidelines for Clinical Classification of BMPR2 Variants in Pulmonary Arterial Hypertension Resolves Variants of Unclear Pathogenicity in ClinVar.
    Hum Mutat. 2025;2025:2475635.
    PubMed    
    Abstract available
    
    

85. MYRONENKO O, Curcic P, Douschan P, Zeder K, et al
    Soluble Transferrin Receptor-1 in Pulmonary Hypertension Associated with COPD.
    Lung. 2025;203:79.
    PubMed    
    Abstract available
    
    

86. ZHENG W, Wang Y, Li Y, Bai C, et al
    Genetic adaptations of innate immune genes in Tibetans: Insights into protection against pulmonary hypertension and hepatitis B virus infection in high-altitude environments.
    Genomics. 2025 Jul 12:111079. doi: 10.1016/j.ygeno.2025.111079.
    PubMed    
    Abstract available
    
    

87. SANTOS RT, Onofre MESF, Barbosa VM, Rocha NN, et al
    Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension.
    J Vis Exp. 2025;.
    PubMed    
    Abstract available
    
    

88. SANTA-ANA-BAYONA MJ, Garcia-Cardenas M, Armendariz-Ferrari JC, Acosta-Gutierrez GH, et al
    Cardiac Complications in Carney Complex: Right Ventricular Outflow Tract Obstruction and Pulmonary Hypertension.
    CASE (Phila). 2025;9:152-156.
    PubMed    
    Abstract available
    
    

89. KOIRALA PC, Koirala R, Karki L, Khadka M, et al
    Common Echocardiographic Diagnoses in Patients at Tertiary Care Center: An Observational Study.
    JNMA J Nepal Med Assoc. 2024;62:714-719.
    PubMed    
    Abstract available
    
    

90. LO MUZIO FP, Caputo A, Statello R, Hu M, et al
    Biventricular electromechanical dysfunction and molecular remodeling in a rat model of advanced pulmonary arterial hypertension.
    J Transl Med. 2025;23:787.
    PubMed    
    Abstract available
    
    

91. SUN L, Li H, Li X, Li Y, et al
    Dysregulation of immune cells and platelet-monocyte aggregates in chronic thromboembolic pulmonary hypertension.
    Respir Res. 2025;26:245.
    PubMed    
    Abstract available
    
    

92. CONDLIFFE R, Kiely DG
    Reaching for the summit in pulmonary arterial hypertension with sotatercept: Results of the ZENITH study.
    Med. 2025;6:100750.
    PubMed    
    Abstract available
    
    

93. LAFFAN SB, Loren K, Takahito K, Sandra T, et al
    Brain Weight Effect of Ambrisentan in Juvenile Rat Toxicity Studies Associated With Breathing Sounds, Apnea, and Sustained Hypoxemia.
    Birth Defects Res. 2025;117:e2504.
    PubMed    
    Abstract available
    
    

94. THATRIMONTRICHAI A, Pakhathirathien P, Praditaukrit M, Maneenil G, et al
    Persistent Pulmonary Hypertension of the Newborn in Very Low Birth Weight Infants: Risk Factors and Clinical Outcomes from a Matched Case-Control Study.
    J Clin Med. 2025;14:4759.
    PubMed    
    Abstract available
    
    

95. TUNCEZ A, Yalcin MU, Tezcan H, Altunkeser BB, et al
    Assessment of Serum suPAR Levels in Patients with Group 1 and Group 4 Pulmonary Hypertension.
    J Clin Med. 2025;14:4671.
    PubMed    
    Abstract available
    
    

96. CHUAIKAEW K, Maneenil G, Thatrimontrichai A, Dissaneevate S, et al
    Mortality Risk Factors and Survival Outcomes in Infants with Persistent Pulmonary Hypertension of the Newborn.
    J Clin Med. 2025;14:4502.
    PubMed    
    Abstract available
    
    

97. GUZELBAG AN, Bas S, Kangel D, Toprak MHH, et al
    Computed Tomography Angiography in Pediatric Pulmonary Hypertension: Evaluating MPA-to-Aortic Ratios as Diagnostic Markers.
    Diagnostics (Basel). 2025;15:1614.
    PubMed    
    Abstract available
    
    

98. DAS R, Deliu N, Toshner MR, Villar SS, et al
    StratosPHere 2: statistical analysis plan for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2.
    Trials. 2025;26:243.
    PubMed    
    Abstract available
    
    

99. ZHANG Y, Qian T, Jiang W, Yuan H, et al
    Integrated bioinformatics identifies ferroptosis biomarkers and therapeutic targets in idiopathic pulmonary arterial hypertension.
    Sci Rep. 2025;15:25187.
    PubMed    
    Abstract available
    
    

100. LITTMAN D, Lovett J, Adelsheimer A, Bloom M, et al
     Severe Pulmonary Hypertension Secondary to Pulmonary Artery Compression With Resolution Following Hodgkin Lymphoma Therapy.
     JACC Case Rep. 2025;30:103950.
     PubMed    
     Abstract available
     
     

101. YONG E, Latief J, Wang Y, Erlinge D, et al
     A lumped parameter model of the coronary circulation incorporating time-varying resistance, intramyocardial pressure and vascular compliance.
     J Biomech. 2025;189:112679.
     PubMed    
     Abstract available
     
     

102. IKEDA M, Cho K, Furuse Y, Onda T, et al
     Genetic features of alveolar capillary dysplasia with misalignment of pulmonary veins in Japanese infants.
     Early Hum Dev. 2025;207:106287.
     PubMed    
     Abstract available
     
     

103. SU J, Wang X, Liu L, Zhang X, et al
     Exploring the influence of pulmonary pathological state on the in vivo fate of inhaled microparticles with different structural characteristics.
     Int J Pharm. 2025;681:125813.
     PubMed    
     Abstract available
     
     

104. PRISCO SZ, Blake M, Kazmirczak F, Moon R, et al
     Lactobacillus Restructures the Micro/Mycobiome to Combat Inflammation-Mediated Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
     Circ Heart Fail. 2025 May 16:e012524. doi: 10.1161/CIRCHEARTFAILURE.124.012524.
     PubMed    
     Abstract available
     
     

105. FUKUDA Y, Oda N, Izumizaki K, Tanaka A, et al
     High Altitude Pulmonary Edema Associated with Climbing Mount Fuji.
     Intern Med. 2025;64:2229-2233.
     PubMed    
     Abstract available
     
     

106. KULKARNI T, Zisman DA, Shlobin OA, Kiely DG, et al
     Study Design and Rationale for the PHINDER Study: Pulmonary Hypertension Screening in Patients with Interstitial Lung Disease for Earlier Detection.
     Pulm Ther. 2025 Jul 25. doi: 10.1007/s41030-025-00307.
     PubMed    
     Abstract available
     
     

107. LAVIOLA D, Manzi G, Recchioni T, Luise MC, et al
     Oral Anticoagulants in Chronic Thromboembolic Pulmonary Hypertension: Tradition or Innovation?
     J Cardiovasc Dev Dis. 2025;12:271.
     PubMed    
     Abstract available
     
     

108. GHANDAKLY EC, Banga A, Kaw R
     Hemodynamic Definitions, Phenotypes, Pathophysiology, and Evaluation of Pulmonary Hypertension Related to Left Heart Disease.
     J Cardiovasc Dev Dis. 2025;12:238.
     PubMed    
     Abstract available
     
     

109. NEELAKANTAN S, Mendiola EA, Zambrano B, Vang A, et al
     Dissecting contributions of pulmonary arterial remodeling to right ventricular afterload in pulmonary hypertension.
     Bioeng Transl Med. 2025;10:e70035.
     PubMed    
     Abstract available
     
     

110. PENG G, Liu Z, Wang W
     IDO-Dependent Tryptophan Metabolites and Endocan as Effective Diagnostic Biomarkers for Pregnancy with Pulmonary Hypertension.
     Int J Womens Health. 2025;17:2205-2216.
     PubMed    
     Abstract available
     
     

111. DIGNAM JP, Aubdool AA, Lowe VR, Perez-Ternero C, et al
     Endothelium-derived C-type natriuretic peptide offsets the pathogenesis of pulmonary hypertension.
     Pharmacol Res. 2025 Jul 22:107870. doi: 10.1016/j.phrs.2025.107870.
     PubMed    
     Abstract available
     
     

112. RYO M, Ishida Y, Hamaguchi M, Hosokawa M, et al
     Anesthesia Management Involving Remimazolam in a Patient With Pulmonary Hypertension and Right Ventricular Failure: A Case Report.
     Cureus. 2025;17:e86568.
     PubMed    
     Abstract available
     
     

113. LIAO XY, Li JJ, Zeng SY, Zhang ZW, et al
     Successful interventional closure of patent ductus arteriosus in three pediatric cases with congenital heart disease and severe pulmonary hypertension: a case series and literature review.
     Front Cardiovasc Med. 2025;12:1628666.
     PubMed    
     Abstract available
     
     

114. DALAVINA J, Costa IP, FarahTeixeira de Carvalho E, Silva JL, et al
     Severity Classification of Functional Impairment Based on ICF Qualifiers: A New Proposal for Assessing Individuals With Pulmonary Hypertension.
     Physiother Res Int. 2025;30:e70090.
     PubMed    
     Abstract available
     
     

115. HUANG Y, Bai Z, Wang L, Liu Z, et al
     Systematic review and meta-analysis of nitrates/nitrites in patients with heart failure or pulmonary hypertension.
     Eur J Med Res. 2025;30:661.
     PubMed    
     Abstract available
     
     

116. RODRIGUEZ-HERRERA AJ, Setembre Batah S, Faci do Marco MJ, Gonzalez-Zambrano CM, et al
     Pulmonary Hypertension Secondary to Fungal Infections: Underexplored Pathological Links.
     Infect Dis Rep. 2025;17:84.
     PubMed    
     Abstract available
     
     

117. KHANZADEH S, Aminizadeh S, Nourigheimasi S, Lucke-Wold B, et al
     The Neutrophil-to-lymphocyte ratio as a diagnostic and prognostic biomarker in pulmonary hypertension: A systematic review.
     Sarcoidosis Vasc Diffuse Lung Dis. 2025;42:14552.
     PubMed    
     Abstract available
     
     

118. FUKUDA Y, Shimokawahara H, Miyagi A, Goten C, et al
     Rescue balloon pulmonary angioplasty in patients with low cardiac output syndrome due to chronic thromboembolic pulmonary hypertension: A case series.
     J Cardiol Cases. 2025;32:15-18.
     PubMed    
     Abstract available
     
     

119. CHEN C, Dong Y, Song N, Qi J, et al
     Pulmonary arterial hypertension caused by coadministration of dasatinib and voriconazole: A case report and literature review.
     Medicine (Baltimore). 2025;104:e42927.
     PubMed    
     Abstract available
     
     

120. ZHANG M, Guo X, Guo W, Wang Y, et al
     Pulmonary arterial hypertension with cardiopulmonary comorbidities: is it a unique phenotype?
     BMC Pulm Med. 2025;25:348.
     PubMed    
     Abstract available
     
     

121. WANG Y, Yin L, Zheng S, Liu A, et al
     LINC00599 Promotes Pulmonary Hypertension via Liquid-Liquid Phase Separation With G3BP1 and MYH9.
     Hypertension. 2025 Jul 22. doi: 10.1161/HYPERTENSIONAHA.124.24511.
     PubMed    
     Abstract available
     
     

122. BARNIKEL M, Milger K, Mertsch P, Arnold P, et al
     Classification and course of pulmonary hypertension associated with end-stage COPD.
     ERJ Open Res. 2025;11:01141-2024.
     PubMed    
     Abstract available
     
     

123. KHAN A, Asghar T, Ali KM, Saeed M, et al
     Trends in mortality from pulmonary hypertension amongst population with congenital heart disease in the United States from 1999 to 2020: A CDC WONDER analysis.
     Int J Cardiol Congenit Heart Dis. 2025;21:100602.
     PubMed    
     Abstract available
     
     

124. SHI W, Kang Y, Wang X, Wang H, et al
     Hereditary hemorrhagic telangiectasia with pulmonary hypertension: a report of three cases.
     J Thorac Dis. 2025;17:4349-4359.
     PubMed    
     Abstract available
     
     

125. PURA KRISHNAMURTHY K, Mahadevappa M, Srinivasan BR, Jayaprakash Narayan H, et al
     Dasatinib Induced Pulmonary Hypertension and Third Space Effusion: A Case Series and Literature Review.
     Hosp Pharm. 2025 Jul 17:00185787251348384. doi: 10.1177/00185787251348384.
     PubMed    
     Abstract available
     
     

126. YAMASHITA J, Ogino H, Masaki K, Taniguchi Y, et al
     Effects of pulmonary endarterectomy and balloon pulmonary angioplasty in older adults with chronic thromboembolic pulmonary hypertension: A sub-analysis of the CTEPH AC registry.
     Int J Cardiol Heart Vasc. 2025;60:101751.
     PubMed    
     Abstract available
     
     

127. LIU R, Li Y, Li B, Liu S, et al
     Innovative nitric oxide delivery technology for postoperative pulmonary hypertension in congenital heart disease patients: a clinical trial.
     BMC Cardiovasc Disord. 2025;25:522.
     PubMed    
     Abstract available
     
     

128. CASTILLO D, Francesqui J, Padilla M, Montani D, et al
     Diagnosis of Pulmonary Hypertension Associated With Lung Disease: A Call for Awareness.
     Arch Bronconeumol. 2025 Jul 5:S0300-2896(25)00231.
     PubMed    
     
     
     

129. VACHON S, Devanagondi R, Dylag A, Wang H, et al
     The effectiveness of pulmonary hypertension screening in infants born preterm.
     Early Hum Dev. 2025;209:106342.
     PubMed    
     Abstract available
     
     

130. YEGAMBARAM M, Sun X, Lu Q, Flores AG, et al
     c-Myc promotes metabolic reprogramming in pulmonary hypertension via the stimulation of glutaminolysis and the reductive tricarboxylic acid cycle.
     Redox Biol. 2025;85:103765.
     PubMed    
     Abstract available
     
     

131. FANG L, Yang T, Nijiati Y, Shahanati D, et al
     Multi-omics analyses reveal that hesperidin ameliorates high-altitude pulmonary hypertension by restoring gut-lung axis homeostasis.
     Phytomedicine. 2025;145:157069.
     PubMed    
     Abstract available
     
     

132. ORDOG K, Horvath O, Toth S, Deres L, et al
     Colchicine as a therapeutic possibility for the treatment of pulmonary arterial hypertension (PAH) in a rat model.
     Biochem Pharmacol. 2025;239:117058.
     PubMed    
     Abstract available
     
     

133. TANG Y, Pan Z, Wen J, Yang Z, et al
     Epicardial adipose tissue associated with right cardiac chamber remodelling in patients with connective tissue disease evaluated by cardiac magnetic resonance: a cross-sectional study.
     Clin Radiol. 2025;87:106958.
     PubMed    
     Abstract available
     
     

134. ZIDAN BMRM, Zehravi M, Kareemulla S, Madhuri KSD, et al
     High-altitude physiology: Understanding molecular, pharmacological and clinical insights.
     Pathol Res Pract. 2025;272:156080.
     PubMed    
     Abstract available
     
     

135. BORHANI A, Nia IY, Zandieh G, Mathai SC, et al
     Semi-quantitative Analysis of Right Ventricular Myocardial First-pass Perfusion Using Cardiac Magnetic Resonance Imaging in Systemic Sclerosis and Pulmonary Arterial Hypertension.
     Acad Radiol. 2025;32:4445-4455.
     PubMed    
     Abstract available
     
     

136. RAMARAJ AB, Breitschopf HV, Holden KI, Gupta VS, et al
     Factors Associated with Early-Childhood Ipsilateral Perfusion Abnormalities among Patients with Congenital Diaphragmatic Hernia.
     J Pediatr. 2025 Apr 23:114622. doi: 10.1016/j.jpeds.2025.114622.
     PubMed    
     Abstract available
     
     

137. WANG X, Yu C, Li M, Cai H, et al
     Identification of serum C4BPA as a potential diagnostic marker of right ventricular remodelling via proteomic analysis.
     ESC Heart Fail. 2025;12:2843-2854.
     PubMed    
     Abstract available
     
     

138. SKOWASCH D, Pausch C, Huscher D, Pittrow D, et al
     Mono and combination therapies in pulmonary arterial hypertension patients with comorbidities: A COMPERA analysis.
     ESC Heart Fail. 2025;12:2726-2735.
     PubMed    
     Abstract available
     
     

139. HARI GOPAL S, Martinek KF, Vacher C, Becker J, et al
     Utility of urinary NT-proBNP in congenital diaphragmatic hernia: a prospective pilot study.
     Pediatr Res. 2024 Oct 16. doi: 10.1038/s41390-024-03600.
     PubMed    
     Abstract available
     
     

140. BLANCAS-NAPOLES CM, Cabrera-Becerra SE, Sierra-Sanchez VM, Ocampo-Ortega SA, et al
     siRNA Targeting ECE-1 Partially Reverses Pulmonary Arterial Hypertensionassociated Damage in a Monocrotaline Model.
     Curr Mol Pharmacol. 2024;17:e18761429283384.
     PubMed    
     Abstract available
     
     

141. AUSTIN ED
     Measuring Activity in Pediatric Pulmonary Hypertension: Expanding Opportunities to Advance Clinical Trial Design and Impact.
     Chest. 2025;168:13-15.
     PubMed    
     
     
     

142. LEARY PJ, Rayner SG, Branch KRH, Hogl L, et al
     Effect of Famotidine on Outcomes in Pulmonary Arterial Hypertension: A Randomized Controlled Trial.
     Chest. 2025;168:189-199.
     PubMed    
     Abstract available
     
     

143. MARON BA
     Precision medicine in pulmonary hypertension: how close are we today?
     Curr Opin Pulm Med. 2025 Jul 8. doi: 10.1097/MCP.0000000000001195.
     PubMed    
     Abstract available
     
     

144. CULLIVAN S, McCourt L, Gaine S
     Important negative trials in pulmonary hypertension.
     Curr Opin Pulm Med. 2025 Jul 8. doi: 10.1097/MCP.0000000000001198.
     PubMed    
     Abstract available
     
     

145. LANG IM
     A reason to celebrate: multimodal treatments and recent improvements in the long-term outcomes of patients with chronic thromboembolic pulmonary hypertension.
     Eur Respir J. 2025;66:2500562.
     PubMed    
     
     
     

146. PRESTON IR, Badesch D, Ghofrani HA, Gibbs JSR, et al
     A long-term follow-up study of sotatercept for treatment of pulmonary arterial hypertension: interim results of SOTERIA.
     Eur Respir J. 2025;66:2401435.
     PubMed    
     Abstract available
     
     

147. MAUS T, Khoche S
     Chronic Thromboembolic Pulmonary Hypertension-An Update for the Anesthesiologist.
     J Cardiothorac Vasc Anesth. 2025 Jun 15:S1053-0770(25)00488.
     PubMed    
     
     
     

148. FUKUSHI K, Goda A, Kohno T, Takeuchi S, et al
     Revised Definition of Pulmonary Hypertension Subtypes Enhances Prognostic Stratification in Hospitalized Heart Failure Patients.
     J Heart Lung Transplant. 2025 Jun 26:S1053-2498(25)02037.
     PubMed    
     Abstract available
     
     

149. KOLAITIS NA, Singer JP, Bartolome S, Chakinala MM, et al
     The landscape of referrals for lung transplantation in pulmonary arterial hypertension: a report from the Pulmonary Hypertension Association Registry.
     J Heart Lung Transplant. 2025 Jun 26:S1053-2498(25)02055.
     PubMed    
     Abstract available
     
     

150. WIEDENROTH CB, Jenkins D, Brenot P, Lang IM, et al
     Management of chronic thromboembolic pulmonary hypertension.
     J Heart Lung Transplant. 2025;44.
     PubMed    
     Abstract available
     
     

151. JAIS X, Tapson V, Fernandes TM, Fadel E, et al
     Diagnosis of chronic thromboembolic pulmonary hypertension.
     J Heart Lung Transplant. 2025;44.
     PubMed    
     Abstract available